Active Ingredient: Quetiapine
For this indication, competent medicine agencies globally authorize below treatments:
For:
Tablet, extended release oral, 50 milligrams quetiapine, one dose, over the duration of 1 day. Afterwards, tablet, extended release oral, 100 milligrams quetiapine, one dose, over the duration of 1 day. Afterwards, tablet, extended release oral, 200 milligrams quetiapine, one dose, over the duration of 1 day. Afterwards, tablet, extended release oral, 300 milligrams quetiapine, once daily.
Prolonged-release quetiapine should be administered at bedtime. The total daily dose for the first four days of therapy is 50 mg (Day 1), 100 mg (Day 2), 200 mg (Day 3) and 300 mg (Day 4). The recommended daily dose is 300 mg. In clinical trials, no additional benefit was seen in the 600 mg group compared to the 300 mg group. Individual patients may benefit from a 600 mg dose. Doses greater than 300 mg should be initiated by physicians experienced in treating bipolar disorder. In individual patients, in the event of tolerance concerns, clinical trials have indicated that dose reduction to a minimum of 200 mg could be considered.
Prolonged-release quetiapine should be administered once daily, without food. The tablets should be swallowed whole and not split, chewed or crushed.
For:
Tablet, extended release oral, 50 milligrams quetiapine, once daily, over the duration of 3 days. Afterwards, tablet, extended release oral, 100 milligrams quetiapine, once daily, over the duration of 4 days. Afterwards, tablet, extended release oral, 150 milligrams quetiapine, once daily.
In elderly patients with major depressive episodes in MDD, dosing should begin with 50 mg/day on Days 1-3, increasing to 100 mg/day on Day 4 and 150 mg/day on Day 8. The lowest effective dose, starting from 50 mg/day should be used. Based on individual patient evaluation, if dose increase to 300 mg/day is required this should not be prior to Day 22 of treatment.
Prolonged-release quetiapine should be administered once daily, without food. The tablets should be swallowed whole and not split, chewed or crushed.
For:
Tablet, film coated oral, 50 milligrams quetiapine, at the end of the day, one dose, over the duration of 1 day. Afterwards, tablet, film coated oral, 100 milligrams quetiapine, at the end of the day, one dose, over the duration of 1 day. Afterwards, tablet, film coated oral, 300 milligrams quetiapine, once daily at the end of the day.
Quetiapine immediate-release quetiapine should be administered once daily at bedtime. The total daily dose for the first four days of therapy is 50 mg (Day 1), 100 mg (Day 2), 200 mg (Day 3) and 300 mg (Day 4). The recommended daily dose is 300 mg. In clinical trials, no additional benefit was seen in the 600 mg group compared to the 300 mg group. Individual patients may benefit from a 600 mg dose. Doses greater than 300 mg should be initiated by physicians experienced in treating bipolar disorder. In individual patients, in the event of tolerance concerns, clinical trials have indicated that dose reduction to a minimum of 200 mg could be considered.
As with other antipsychotics, Seroquel should be used with caution in the elderly, especially during the initial dosing period. The rate of dose titration may need to be slower, and the daily therapeutic dose lower, than that used in younger patients, depending on the clinical response and tolerability of the individual patient. The mean plasma clearance of quetiapine was reduced by 30-50% in elderly subjects when compared to younger patients.
Efficacy and safety has not been evaluated in patients over 65 years with depressive episodes in the framework of bipolar disorder.
Quetiapine immediate-release quetiapine should be administered once daily at bedtime.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.